Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rilapladib (SB 659032) is a selective inhibitor of Lipoprotein-Associated Phospholipase A2(Lp-PLA2, IC50 = 230 pM) and an antagonist of the platelet activating factor receptor.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 21,500 | |||
5 mg | 在庫あり | ¥ 55,000 | |||
10 mg | 在庫あり | ¥ 89,500 | |||
25 mg | 在庫あり | ¥ 150,500 | |||
50 mg | 在庫あり | ¥ 214,000 | |||
100 mg | 在庫あり | ¥ 291,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 89,000 |
説明 | Rilapladib (SB 659032) is a selective inhibitor of Lipoprotein-Associated Phospholipase A2(Lp-PLA2, IC50 = 230 pM) and an antagonist of the platelet activating factor receptor. |
ターゲット&IC50 | Lp-PLA2:230 pM |
In vitro | Rilapladib reduces the PAF biological activity and levels, thereby reducing Lp-PLA2 biosynthesis and preventing the possible adverse effects of Lp-PLA2 [2]. |
別名 | SB 659032 |
分子量 | 735.8 |
分子式 | C40H38F5N3O3S |
CAS No. | 412950-08-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 78 mg/mL (106 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rilapladib 412950-08-4 Metabolism Phospholipase SB659032 SB-659032 SB 659032 Inhibitor inhibitor inhibit